Business profile not generated.
Run python -m application.cli.business_profile run --market US --one PLRX, then regenerate the site.
Issue 000 | U.S. Pilot | US
PLRX
PLIANT THERAPEUTICS, INC.
Passing
Verified
10-Q | 2026-05-11
Filing currency: USD
Margin of Safety
47.3%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 174,930,000USD
- Total Liabilities
- 37,430,000USD
- NCAV
- 137,500,000USD
- Cash
- 22,190,000USD
- NCAV per share
- 2.22USD/share
- Evidence
- 6 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1,580,000 | 9,685,000 | 7,572,000 | 41,817,000 |
| Operating Income | -156,373,000 | -228,365,000 | -184,145,000 | -127,200,000 | -97,535,000 | -41,645,000 |
| Net Income | -149,344,000 | -210,304,000 | -161,336,000 | -123,321,000 | -97,263,000 | -41,533,000 |
| Cash From Operations | -128,336,000 | -155,503,000 | -116,361,000 | -94,631,000 | -75,443,000 | -37,271,000 |
| Capex | -374,000 | -3,848,000 | -921,000 | -1,760,000 | -1,953,000 | -1,532,000 |
| Free Cash Flow | -128,710,000 | -159,351,000 | -117,282,000 | -96,391,000 | -77,396,000 | -38,803,000 |
| Cash And Equivalents | 45,445,000 | 71,188,000 | 63,234,000 | 33,685,000 | 51,665,000 | 50,882,000 |
| Accounts Receivable | n/a | n/a | 0 | 1,983,000 | 1,998,000 | 9,279,000 |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 196,448,000 | 362,264,000 | 505,502,000 | 340,311,000 | 209,441,000 | 290,754,000 |
| Total Assets | 225,228,000 | 396,949,000 | 512,154,000 | 350,613,000 | 221,215,000 | 295,526,000 |
| Total Current Liabilities | 16,365,000 | 33,218,000 | 28,524,000 | 23,913,000 | 16,831,000 | 11,599,000 |
| Total Liabilities | 44,023,000 | 92,868,000 | 38,578,000 | 37,271,000 | 22,156,000 | 12,465,000 |
| Shareholders Equity | 181,205,000 | 304,081,000 | 473,576,000 | 313,342,000 | 199,059,000 | 283,061,000 |
| Shares Outstanding | 61,449,290 | 60,860,838 | 59,921,002 | 48,941,254 | 36,083,301 | 35,552,795 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 |
| Weighted Avg Shares Basic | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | 0 | 0 | 248,000 | 1,332,000 | 1,965,000 | 1,482,000 | 4,989,000 | 1,249,000 | 1,999,000 | 1,610,000 | 1,789,000 |
| Operating Income | -21,772,000 | -23,577,000 | -28,269,000 | -45,592,000 | -58,935,000 | -53,320,000 | -62,014,000 | -60,639,000 | -52,392,000 | -47,037,000 | -47,685,000 | -47,328,000 | -42,095,000 | -37,400,000 | -31,947,000 | -29,642,000 | -28,211,000 | -24,599,000 | -27,113,000 | -22,904,000 |
| Net Income | -20,040,000 | -23,577,000 | -26,301,000 | -43,300,000 | -56,166,000 | -49,732,000 | -57,763,000 | -55,854,000 | -46,955,000 | -41,109,000 | -41,487,000 | -41,192,000 | -37,548,000 | -35,060,000 | -30,615,000 | -29,546,000 | -28,100,000 | -24,531,000 | -27,045,000 | -22,831,000 |
| Cash From Operations | -19,229,000 | -17,788,000 | -21,081,000 | -40,603,000 | -48,864,000 | -47,662,000 | -32,273,000 | -45,297,000 | -30,271,000 | -25,102,000 | -36,224,000 | -24,759,000 | -30,276,000 | -31,239,000 | -18,498,000 | -24,396,000 | -20,498,000 | -19,865,000 | -22,510,000 | -19,403,000 |
| Capex | 0 | 0 | 0 | -112,000 | -262,000 | -209,000 | -896,000 | -1,251,000 | -1,492,000 | -61,000 | -94,000 | -603,000 | -163,000 | -166,000 | -696,000 | -254,000 | -644,000 | -592,000 | -480,000 | -639,000 |
| Free Cash Flow | -19,229,000 | -17,788,000 | -21,081,000 | -40,715,000 | -49,126,000 | -47,871,000 | -33,169,000 | -46,548,000 | -31,763,000 | -25,163,000 | -36,318,000 | -25,362,000 | -30,439,000 | -31,405,000 | -19,194,000 | -24,650,000 | -21,142,000 | -20,457,000 | -22,990,000 | -20,042,000 |
| Cash And Equivalents | 22,190,000 | 45,445,000 | 93,732,000 | 86,820,000 | 91,936,000 | 71,188,000 | 79,616,000 | 80,386,000 | 114,297,000 | 63,234,000 | 57,679,000 | 54,951,000 | 102,527,000 | 33,685,000 | 44,617,000 | 25,070,000 | 32,545,000 | 51,665,000 | 45,231,000 | 35,193,000 |
| Total Current Assets | 174,930,000 | 196,448,000 | 245,588,000 | 267,444,000 | 311,191,000 | 362,264,000 | 410,031,000 | 447,553,000 | 489,898,000 | 505,502,000 | 534,335,000 | 565,701,000 | 588,227,000 | 340,311,000 | 365,965,000 | 173,526,000 | 185,363,000 | 209,441,000 | 228,584,000 | 250,719,000 |
| Total Liabilities | 37,430,000 | 44,023,000 | 76,294,000 | 79,742,000 | 87,606,000 | 92,868,000 | 99,843,000 | 91,052,000 | 84,273,000 | 38,578,000 | 37,416,000 | 41,826,000 | 35,961,000 | 37,271,000 | 40,187,000 | 36,831,000 | 23,229,000 | 22,156,000 | 13,681,000 | 11,736,000 |
| Shares Outstanding | 61,914,569 | 61,449,290 | 61,449,290 | 61,386,183 | 61,386,183 | 60,860,838 | 60,849,503 | 60,425,144 | 60,318,542 | 59,921,002 | 59,890,980 | 59,222,685 | 58,978,902 | 48,941,254 | 48,749,842 | 36,182,297 | 36,162,459 | 36,083,301 | 35,977,294 | 35,853,916 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 61,803,467 | 61,366,887 | 61,406,475 | 61,386,183 | 61,222,676 | 60,538,639 | 60,730,935 | 60,382,796 | 60,180,921 | 58,719,083 | 59,688,451 | 59,172,869 | 56,057,603 | 42,015,908 | 46,799,058 | 36,173,135 | 36,116,440 | 35,846,421 | 35,906,303 | 35,746,922 |
| Weighted Avg Shares Basic | 61,803,467 | 61,366,887 | 61,406,475 | 61,386,183 | 61,222,676 | 60,538,639 | 60,730,935 | 60,382,796 | 60,180,921 | 58,719,083 | 59,688,451 | 59,172,869 | 56,057,603 | 42,015,908 | 46,799,058 | 36,173,135 | 36,116,440 | 35,846,421 | 35,906,303 | 35,746,922 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 174,930,000USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001746473/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001746473\companyfacts.json |
| Total Liabilities | 37,430,000USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001746473/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001746473\companyfacts.json |
| Cash | 22,190,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001746473/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001746473\companyfacts.json |
| Shares Outstanding | 61,914,569 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001746473/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001746473\companyfacts.json |
| NCAV | 137,500,000USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 2.22USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 47.3% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001746473
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001746473\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001746473\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 22
- Imported At
- 2026-07-04T23:04:36+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001746473-26-000090
- CIK
- 0001746473
- Mary Filing Date
- 2026-05-11
- Filing Currency
- USD
- Internal Discount
- 47.3%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-11; mary_accession=0001746473-26-000090; mary_cik=0001746473; gnni_supporting_filing_date=2026-05-11; internal_discount=0.473163; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.